3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
22
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Smoking
1
Motor Activity
1
Depression
1
Breast Neoplasms
1
Anxiety Disorders
1
Alcohol Drinking
1
Interventions
Cisplatin
22
Fluorouracil
21
Radiotherapy
18
Gemcitabine
17
Docetaxel
16
Oxaliplatin
15
Paclitaxel
14
Carboplatin
13
Capecitabine
13
Bevacizumab
13
Leucovorin
11
Cyclophosphamide
11
Irinotecan
10
Drug Therapy
10
Cytarabine
9
Saline Solution
7
Magnetic Resonance Spectroscopy
7
Letrozole
7
Dexamethasone
7
Rituximab
6
Nivolumab
6
Methotrexate
6
Exercise
6
Etoposide
6
Electroporation
6
Doxorubicin
6
pembrolizumab
5
Pemetrexed
5
Metformin
5
Melphalan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Completed
×
Mindfulness-Based Stress Reduction
×
Clear all
NCT00990977
2015-06-30
MICA
Danish Cancer Society
Phase 2/3
Completed
336 enrolled